Interleukin-21 augments the efficacy of T-cell therapy by eliciting concurrent cellular and humoral responses.
about
Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer VaccinationCytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regressionAntitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10Requirement of Innate Immunity in Tumor-Bearing Mice Cured by Adoptive Immunotherapy Using Tumor-Draining Lymph Nodes.Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus.Antitumor activity of T cells generated from lymph nodes draining the SEA-expressing murine B16 melanoma and secondarily activated with dendritic cells.In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy.Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer.Treatment of lymphoma with adoptively transferred T cells.IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways.Enhancing adoptive immunotherapy of cancer.Eliciting protective immune responses against murine myeloma challenge in lymphopenia mice through adoptive transfer of tumor antigen-specific lymphocytes and immunization of tumor vaccine secreting mIL-21.Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.
P2860
Q28068378-7D805254-A587-4B5A-903B-7372D9CF2E10Q33680566-50E51EEC-F213-400F-B39D-2D929382D688Q35146131-79D52312-F39D-43CC-91D8-923EAE00FCE8Q35554861-F2EC1038-FC46-4CCB-A894-9ABDDAA10FF5Q35605398-B79DD3F3-B830-4DA2-913B-D9BB560858E0Q36642484-440F1068-7845-4732-A0D9-30BBD7FC81C0Q37073501-3D770A2B-0245-4AF6-A292-FDF38C21FF7DQ37086932-4D6C10E0-C81A-47E9-83AE-EF456247C7E3Q37346893-962E5F81-5966-406A-AE06-258DBA0EFE67Q37419728-BE8DDC67-1CDD-4AE5-A01C-D4E159AA2A36Q37645042-090D2BBD-2ECA-456B-974B-3046B531B21FQ37687429-6FF50158-3F16-4B19-A36C-5C1D537CE458Q39694463-8030FAB6-1C5C-4853-B5B4-6A3429C70D52Q41850484-99F8DD41-5D18-4F39-B0A7-B8D462566F98Q42415554-3E1FD8D2-63E7-4088-B047-668D4DAF29BB
P2860
Interleukin-21 augments the efficacy of T-cell therapy by eliciting concurrent cellular and humoral responses.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Interleukin-21 augments the ef ...... ellular and humoral responses.
@ast
Interleukin-21 augments the ef ...... ellular and humoral responses.
@en
Interleukin-21 augments the ef ...... ellular and humoral responses.
@nl
type
label
Interleukin-21 augments the ef ...... ellular and humoral responses.
@ast
Interleukin-21 augments the ef ...... ellular and humoral responses.
@en
Interleukin-21 augments the ef ...... ellular and humoral responses.
@nl
prefLabel
Interleukin-21 augments the ef ...... ellular and humoral responses.
@ast
Interleukin-21 augments the ef ...... ellular and humoral responses.
@en
Interleukin-21 augments the ef ...... ellular and humoral responses.
@nl
P2093
P2860
P1433
P1476
Interleukin-21 augments the ef ...... ellular and humoral responses.
@en
P2093
Alfred E Chang
Bruce G Redman
Guihua Jiang
Jianhua Huang
Seagal Teitz-Tennenbaum
Steven D Hughes
Takekazu Iuchi
P2860
P304
P356
10.1158/0008-5472.CAN-07-5530
P407
P577
2008-06-01T00:00:00Z